ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol Clinical trials research involving human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback